Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 8;22(1):25.
doi: 10.1186/s12910-021-00588-5.

Experts' moral views on gene drive technologies: a qualitative interview study

Affiliations

Experts' moral views on gene drive technologies: a qualitative interview study

N de Graeff et al. BMC Med Ethics. .

Abstract

Background: Gene drive technologies (GDTs) promote the rapid spread of a particular genetic element within a population of non-human organisms. Potential applications of GDTs include the control of insect vectors, invasive species and agricultural pests. Whether, and if so, under what conditions, GDTs should be deployed is hotly debated. Although broad stances in this debate have been described, the convictions that inform the moral views of the experts shaping these technologies and related policies have not been examined in depth in the academic literature.

Methods: In this qualitative study, we interviewed GDT experts (n = 33) from different disciplines to identify and better understand their moral views regarding these technologies. The pseudonymized transcripts were analyzed thematically.

Results: The respondents' moral views were principally influenced by their attitudes towards (1) the uncertainty related to GDTs; (2) the alternatives to which they should be compared; and (3) the role humans should have in nature. Respondents agreed there is epistemic uncertainty related to GDTs, identified similar knowledge gaps, and stressed the importance of realistic expectations in discussions on GDTs. They disagreed about whether uncertainty provides a rationale to refrain from field trials ('risks of intervention' stance) or to proceed with phased testing to obtain more knowledge given the harms of the status quo ('risks of non-intervention' stance). With regards to alternatives to tackle vector-borne diseases, invasive species and agricultural pests, respondents disagreed about which alternatives should be considered (un)feasible and (in)sufficiently explored: conventional strategies ('downstream solutions' stance) or systematic changes to health care, political and agricultural systems ('upstream solutions' stance). Finally, respondents held different views on nature and whether the use of GDTs is compatible with humans' role in nature ('interference' stance) or not ('non-interference stance').

Conclusions: This interview study helps to disentangle the debate on GDTs by providing a better understanding of the moral views of GDT experts. The obtained insights provide valuable stepping-stones for a constructive debate about underlying value conflicts and call attention to topics that deserve further (normative) reflection. Further evaluation of these issues can facilitate the debate on and responsible development of GDTs.

Keywords: Ethics; Gene drives; Gene editing; Qualitative research.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. The National Academies of Sciences Engineering & Medicine (NASEM) Gene drives on the horizon: advancing science, navigating uncertainty, and aligning research with public values. Washington, DC: The National Academies Press; 2016. - PubMed
    1. Oye KA, Esvelt K, Appleton E, Catteruccia F, Church G, Kuiken T, et al. Regulating gene drives. Science. 2014;345(61):626–628. doi: 10.1126/science.1254287. - DOI - PubMed
    1. Royal Society. Gene drive research—why it matters. 2018. https://royalsociety.org/~/media/policy/Publications/2018/08-11-18-gene-....
    1. Champer J, Buchman A, Akbari OS. Cheating evolution: engineering gene drives to manipulate the fate of wild populations. Nat Rev Genet. 2016;17(3):146–159. doi: 10.1038/nrg.2015.34. - DOI - PubMed
    1. Alphey L. Can CRISPR-Cas9 gene drives curb malaria? Nat Biotechnol. 2016;34(2):149–150. doi: 10.1038/nbt.3473. - DOI - PubMed

Publication types

LinkOut - more resources